Skip to main content
. 2023 Jul 17;3:98. doi: 10.1038/s43856-023-00329-2

Table 1.

ReproTox-KG node and edge sources and enumeration.

Assertion edge type Name Relationship Reference Nodes/nodes/edges
Birth defect–gene HPO Genes known to be associated with a birth defect Human Phenotype Ontology 599/5093/127,023
Geneshot Genes co-mentioned with birth-defect terms in publications Geneshot 32/1091/1565
Birth defect–drug FDA Adverse Event Reporting System (Female/Male) Drugs with reported adverse events related to birth defects FDA Adverse Event Reporting System 32/94/372
Drugshot Drugs co-mentioned with birth-defect terms in publications Drugshot 679/2207/13,000
Drug–gene IDG (Drug Target) Drugs with known human gene targets Target Central Resource Database 1363/1034/7326
SigCom LINCS Drug-to-Gene (upregulates/ downregulates) Drugs that up- or down-regulate genes across the LINCS L1000 signatures SigCom LINCS 4523/4419/225,509
Drug–drug LINCS Drugs Cosine Similarity Drugs that induce similar gene expression patterns across LINCS L1000 signatures based on cosine similarity SigCom LINCS 4523/3449/20,785
Gene–gene ARCHS4 (positively/ negatively correlated) Genes positively or negatively correlated across ARCHS4 gene expression samples ARCHS4 17,964/12,185/ 170,801

The ReproTox-KG is made of entities (nodes) representing birth defects, genes, and drugs that are connected based on semantic assertions (edges/relationships) extracted from different sources. The table lists the type of assertion, the nature of the relationship, the original source from where the assertion was extracted from, and the number of entities and relations for each entry in the table.